Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Effects of nanosilymarin and conditioned medium of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells co-cultured with HeLa cells.

Daneshi N., Mahmoudi M., Rezaee SA., Khoshmirsafa M., Salar N., Kheradmand S.

Laboratory Study on Chronic Inflammation, Immune Modulation, published in BMC Complement Med Ther (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
BMC Complement Med Ther (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41699595
PMCID
PMC13011651
DOI
10.1186/s12906-026-05278-6

Abstract (original English)

INTRODUCTION: Cervical cancer is the fourth most common malignancy in females worldwide. Silymarin, a flavonoid with established anti-inflammatory properties, shows promise in oncology. Conditioned medium (CM) of Mesenchymal stem cell (MSC) exerts paracrine immunomodulatory effects. This study evaluated the combined impact of CM of adipose tissue-derived MSC (AD-MSC) and nanosilymarin on peripheral blood mononuclear cells (PBMC) from healthy donors co-cultured with HeLa cervical cancer cells. METHODS: AD-MSCs were isolated from adipose tissue via collagenase I digestion, characterized by immunophenotyping and multilineage differentiation potential. Apoptosis (Annexin V/PI), proliferation (MTT assay), and gene expression of IFN-γ, TNF-α, IL-4, and TGF-β (qRT-PCR) were assessed in PBMC treated with AD-MSC-CM (50%) and/or nanosilymarin (25 µM) for 48 h, in monoculture or HeLa co-culture. RESULTS: In PBMC-HeLa co-culture, nanosilymarin (different concentrations) with 50% MSC-CM significantly reduced PBMC proliferation. Nanosilymarin (25 µM) plus MSC-CM induced marked HeLa apoptosis. Both agents together upregulated IFN-γ expression in PBMC, in monoculture and co-culture, without altering TNF-α, IL-4, or TGF-β. CONCLUSION: Nanosilymarin combined with AD-MSC-CM enhances PBMC-mediated anti-tumor immunity via IFN-γ upregulation and promotes HeLa apoptosis, suggesting synergistic potent

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansLeukocytes, MononuclearCulture Media, ConditionedCoculture TechniquesMesenchymal Stem CellsHeLa CellsFemaleCell ProliferationAdipose TissueApoptosis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research